For further information, contact:
R. Scott Ferren, Pharm.D., BCIDP
PGY2 Infectious Diseases Pharmacy Residency Program Director
UTMB Health ASHP-accredited PGY2 - INFECTIOUS dISEASES Pharmacy Residency Program Outcomes
- Providing safe and effective patient care to a diverse range of patients in collaboration with the health care team
- Establish and perform evidence-based antimicrobial stewardship strategies
- Exercising leadership and management skills
- Provide teaching, education, and dissemination of knowledge
Program Structure 2020-2021*
The purpose of this structure is to comply with the PGY2 program purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
|Orientation||Required Rotations†||Elective Rotations†|
|First month of the residency (July)|
Residency Project Selection
Bugs and Drugs
Longitudinal Practice Experiences
* The resident will spend at least 2/3 of his/her time in direct patient care. Direct patient care by pharmacists will be defined as activities performed by pharmacists with the intent of contributing to positive pharmacotherapeutic and health outcomes of individual patients. Care is in collaboration and communication with other members of the health care team with responsibilities for the individual patient and is achieved directly with patients and caregivers face-to-face, telephonically, virtually, or in writing.
†The learning experiences are typically sequenced per discussion with the resident and RPD, based upon resident interests and rotations completed as a student, and preceptor availability. The first 5 rotations are scheduled in July and the final 5 rotations are scheduled in December after the Midyear Clinical Meeting.